REFERENCES
- Grob, C.S.; Danforth, A.L.; Chopra, G.S.; Hagerty, M.; McKay, C.R.; Halberstadt, A.L. & Greer, G.R. 2011. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68: 71–8.
- Grof, S.; Goodman, L.E.; Richards, W.A. & Kurland, A.A. 1973. LSD-assisted psychotherapy in patients with terminal cancer. International Pharmacopsychiatry 8: 129–44.
- Hofmann, A.; Frey, A.; Ott, H.; Petr, Z.T. & Troxler, F. 1958. [Elucidation of the structure and the synthesis of psilocybin]. Experientia 14: 397–9.
- Hofmann, A. & Troxler, F. 1963. Esters of Indoles (U.S. Patent 3,075,992)., Basel, Switzerland: Sandoz Ltd.
- Kast, E. 1966. LSD and the dying patient. Chicago Medical School Quarterly 26: 80–7.
- Kast, E.C. & Collins, V.J. 1964. Lysergic acid diethylamide as an analgesic agent. Anesthesia and Analgesia 43: 285–91.
- Krebs, T.S. & Johansen, P.O. 2012. Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology 26: 994–1002.
- Marona-Lewicka, D.; Thisted, R.A. & Nichols, D.E. 2005. Distinct temporal phases in the behavioral pharmacology of LSD: Dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology (Berl) 180: 427–35.
- Moreno, F.A. & Delgado, P.L. 1997. Hallucinogen-induced relief of obsessions and compulsions. American Journal of Psychiatry 154: 1037–8.
- Nichols, D.E.; Lloyd, D.H.; Hoffman, A.J.; Nichols, M.B. & Yim, G.K. 1982. Effects of certain hallucinogenic amphetamine analogues on the release of [3H] serotonin from rat brain synaptosomes. Journal of Medicinal Chemistry 25: 530–5.
- Pahnke, W.N.; Kurland, A.A.; Unger, S.; Savage, C. & Grof, S. 1970. The experimental use of psychedelic (LSD) psychotherapy. Journal of the American Medical Association 212: 1856–63.
- Strassman, R.J. 1984. Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease 172: 577–95.
- Strassman, R.J. 1991. Human hallucinogenic drug research in the United States: A present-day case history and review of the process. Journal of Psychoactive Drugs 23: 29–38.
- Strassman, R.J. & Qualls, C.R. 1994. Dose-response study of N,N-dimethyltryptamine in humans: I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry 51: 85–97.
- Strassman, R.J.; Qualls, C.R.; Uhlenhuth, E.H. & Kellner, R. 1994. Dose-response study of N,N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry 51: 98–108.